Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation. | J Med Chem | 2026 | 42172174 | PubTator, text mining | PubMed |
| Generation of iPSC lines from myotonic dystrophy type 1 patients with varying CTG repeat lengths. | Stem Cell Res | 2026 | 42133999 | PubTator, text mining | PubMed |
| Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer disease. | Am J Hum Genet | 2026 | 42066773 | PubTator, text mining | PubMed |
| Integrated Proteomics Reveal ALDH1A1 as an Oncogenic Driver and Regulatory Hub in Hepatocellular Carcinoma. | Cancer Genomics Proteomics | 2026 | 42055623 | PubTator, text mining | PubMed |
| Undiagnosed Maternal Myotonic Dystrophy Type 1 Revealed by Congenital Myotonic Dystrophy in the Neonate. | Cureus | 2026 | 42037975 | PubTator, text mining | PubMed |
| [Two cases of congenital myotonic dystrophy type 1 caused by DMPK gene variants]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | 42015707 | PubTator, text mining | PubMed |
| Therapeutic Strategies Targeting the Molecular Pathogenesis of Myotonic Dystrophy Type 1: Current Status and Future Directions. | Mol Diagn Ther | 2026 | 41996006 | PubTator, text mining | PubMed |
| Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion. | Mol Psychiatry | 2026 | 41986744 | PubTator, text mining | PubMed |
| Targeted long-read sequencing for high-resolution repeat profiling in myotonic dystrophy type 1. | Exp Mol Med | 2026 | 41974889 | PubTator, text mining | PubMed |
| Population-scale repeat expansions elucidate disease risk and brain atrophy. | Nature | 2026 | 41951733 | PubTator, text mining | PubMed |
| Generation and characterization of two human induced pluripotent stem cell lines from myotonic dystrophy type 1 patients. | Stem Cell Res | 2026 | 41946260 | PubTator, text mining | PubMed |
| Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood. | Neurol Genet | 2026 | 41938492 | PubTator, text mining | PubMed |
| DMPK 3' untranslated repeat expansions in unexplained sudden cardiac death in the young. | Eur Heart J | 2026 | 41934227 | PubTator, text mining | PubMed |
| MBNL proteins in health, disease, and therapeutic applications. | Nucleic Acids Res | 2026 | 41925231 | PubTator, text mining | PubMed |
| Abstracts from The XXV Brazilian Diabetes Society Meeting. | Diabetol Metab Syndr | 2026 | 41913261 | PubTator, text mining | PubMed |
| Commitment to Myogenic Differentiation Significantly Aggravates the RNA Phenotype in Myotonic Dystrophy Type 1. | Neuropathol Appl Neurobiol | 2026 | 41848171 | PubTator, text mining | PubMed |
| Expanding repeats, expanding impact: Somatic instability in myotonic dystrophy type 1. | J Neuromuscul Dis | 2026 | 41830076 | PubTator, text mining | PubMed |
| Delpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study. | Mol Ther | 2026 | 41821312 | PubTator, text mining | PubMed |
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | 41797662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=2